Unlock the secrets of cultivating Panaeolus cinctulus mushrooms. Discover its psychedelic properties, identification tips, and expert growing techniqu...
Cybin shareholders approve the acquisition of Small Pharma with 99.4% of the vote. The post Cybin Shareholders Approve Acquisition of Small Pharma appeared...
Hear from experienced educators and operators on how to navigate the demanding need for education in the space of psychedelic training and therapy. Participants...
Pharma stocks and the biotech sector can offer explosive gains. It also offers incredibly crushing defeats in which share prices decline precipitously....
Jupiter Acquisition in a regulatory filing included an investor presentation promoting its proposed merger with Filament Health, a Canadian clinical‐stage...
Welcome to the News You Might Have Missed, a weekly roundup of psychedelic medicine news to help you catch up and stay informed. The post News...
Numinus has announced an at-the-market equity offering program that allows the company to issue and sell up to $10,000,000 (CAD) of common shares. The...
The exact number of shares to be sold will be determined by Numinus' financier. The post Numinus to Sell C$10M Worth of New Shares Through Equity...
Cybin moves its lead program forward as it completes enrollment of its Phase 2 study of major depressive disorder. The post Cybin Completes Phase 2 Enrollment...
Ord Minnett agrees despite Paine Schwartz Partners' lower second offer for CGH, the deal for our largest fruit/veg supplier will ... Read More The post...